complications of cirrhosis review
TRANSCRIPT
![Page 1: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/1.jpg)
COMPLICATIONS OF CIRRHOSIS
Arjmand Mufti
UTSW
![Page 2: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/2.jpg)
Outline
• Portal hypertension
• Ascites
• Hepatic encephalopathy
• Hepatorenal syndrome
• Hypoalbuminemia and coagulopathy
• Hepatocellular carcinoma
• Prognostic Tools
![Page 3: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/3.jpg)
CirrhosisNormal
Nodules
Irregular surface
Cirrhosis
![Page 4: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/4.jpg)
Definition• Diffuse fibrosis following hepatocyte
destruction and nodular regeneration• Multiple causes
– All may lead to cirrhosis
• Asymptomatic (compensated)• Symptomatic (decompensated)
– portal hypertension– hepatic failure
![Page 5: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/5.jpg)
The Natural History of cirrhosis
Decompensation:•Variceal hemorrhage
•Ascites•Encephalopathy
•Jaundice
D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217-231.
![Page 6: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/6.jpg)
Liver insufficiency
Variceal hemorrhage
Decompensated Cirrhosis
Ascites
Encephalopathy
Jaundice
Portal hypertension SBP
HRS
Compensated Cirrhosis
5- 7%per year
Complications of Cirrhosis Result from Portal Hypertension or Liver Insufficiency
![Page 7: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/7.jpg)
Natural History of Cirrhosis
Stage Definition 1-year mortality
Median Survival
1 Compensated without varices
1% >12 years
2 Compensated with varices 3%
3 Decompensated with ascites without variceal hemorrhage
20% ~2 years
4 Decompensated with/out ascites with variceal hemorrhage
57%
D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217-231.
![Page 8: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/8.jpg)
Clinical Presentation
• Symptoms– Anorexia– Weight loss– Generalized
weakness
– Easy fatigability
– Nausea
– Vomiting– Diarrhea
• Exam Findings– Spider angiomatas– Palmar erythema– Gynecomastia– Testicular atrophy– Leuconychia– Parotid gland
hypertrophy– Dupuytren’s contractures– Clubbing– Jaundice
Asymptomatic
![Page 9: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/9.jpg)
Portal Hypertension
![Page 10: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/10.jpg)
Arroyo, V. & Fernández, J. Nat. Rev. Nephrol. 2011
Mechanisms Leading to Circulatory & Renal Dysfunction in Cirrhosis
![Page 11: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/11.jpg)
6040 80 100 120 140 1600
40
60
80
20
200
100
Months
Probability of survival
All patients with cirrhosis
Decompensated cirrhosis
180
Gines et. al., Hepatology 1987;7:122
Median survival~ 9 years
Median survival~ 9 years
Median survival~ 1.6 years
Median survival~ 1.6 years
Decompensation shortens survival
![Page 12: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/12.jpg)
Venous Anatomy
![Page 13: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/13.jpg)
Cirrhotic Liver
![Page 14: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/14.jpg)
Pressure Measurements
Portal Venous Pressure (PVP)
Normal = 5-10 mm Hg
Hepatic Venous Pressure Gradient (HVPG)
= portal venous pressure - hepatic venous pressure or RA pressure
Normal = 1-5 mm Hg
PORTAL HTN
![Page 15: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/15.jpg)
• HVPG ≥6 mm Hg• HVPG ≥10mm Hg – clinically significant• HVPG ≥12 mmHg, risk of variceal
bleeding and the development of ascites• HVPG >20 mmHg – bleeding unlikely to
respond to conventional therapy
Definition of Portal Hypertension
![Page 16: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/16.jpg)
PathophysiologyPortal Hypertension
• Increased intrahepatic vascular resistance– Fixed component
• Sinusoidal fibrosis• Compression by regenerative nodules
– Functional component• Vasoconstriction
– Deficiency in intrahepatic NO– Enhanced activity of vasoconstrictors
![Page 17: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/17.jpg)
Classification Type Examples
• Prehepatic Portal or splenic vein thrombosis
Presinusoidal Schistosomiasis• Intrahepatic Sinusoidal Cirrhosis
Postsinusoidal Veno-occlusive disease
• Posthepatic Hepatic vein thrombosisConstrictive pericarditis
![Page 18: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/18.jpg)
Varices: Portosystemic Collateral Formation
• Esophageal varices
• Gastric varices
• Intraabdominal varices
• Caput medusa
• Rectal varices
![Page 19: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/19.jpg)
Variceal Bleeding
35-80% 25-40%
50-70%
Survival Death
Rebleed
30-50%
70%
![Page 20: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/20.jpg)
Varices
• Common lethal complication
• ~ 50% of patients with cirrhosis
• More likely to bleed in more decompensated disease– 40% of Child A – 85% of Child C
Practice Guidelines: Am J Gastroenterol. 2007;102:2086-2102
![Page 21: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/21.jpg)
%Patients with
varices
100
60
40
20
0
Overalln=494
Child A
n=346
Child B
n=114
80
Child C
n=34
Large
Medium
Small
Pagliaro et al., In: Portal Hypertension: Pathophysiology and Management, 1994: 72
Prevalence and Size of Esophageal Varices in Patients with Newly-Diagnosed Cirrhosis
![Page 22: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/22.jpg)
LaPlace’s Law
T = wall tension
P1 = intravariceal pressure
P2 = esophageal lumen pressure
r = vessel radius
W = wall thickness
T = (P1-P2) x (r/W)
![Page 23: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/23.jpg)
Variceal Bleed: Risk Factors
• High Gradient• Large esophageal varices• Endoscopic features
– red wale markings– cherry red signs
![Page 24: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/24.jpg)
Varices
• All patients with new dx of cirrhosis should undergo EGD to screen for varices
• High risk for bleeding:– Childs B/C (more
evidence of decompensation)
– Large varices– Red wale markings
![Page 25: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/25.jpg)
Varices
• Primary prophylaxis (never bled)– If no varices: no need for nonselective B
blocker– If small varices: no long term evidence to use B
blocker unless red signs present– If large varices:
• High risk patient (red wale, childs B/C): B blocker (nadolol/ propranolol) or prophylactic banding
• Low risk patients: B blocker
– Titrate B blocker to max tolerated dose
![Page 26: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/26.jpg)
Got one for you…Variceal Bleed
• Blood transfusion: Target Hgb=8• Antibiotics: norfloxacin, IV cipro, ceftriaxone
(probably best)• Vasopressin, telipressin, octreotide, vapreotide x
3-5 days– Splanchnic vasoconstriction, reduced portal flow
• EGD within 12 hours– Banding(almost always) or sclerotherapy (rare)
![Page 27: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/27.jpg)
Variceal Bleed: When Banding Fails
• Balloon Tamponade (Blakemore / Minnesota tube) temporizing measure for up to 24 hours
• TIPS
![Page 28: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/28.jpg)
After the Bleed
• Secondary prophylaxis– All patients who have has a variceal bleed– Combination of B Blocker and serial banding– Continue banding (usually outpt) until varices
are eradicated
![Page 29: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/29.jpg)
Take Home: Varices
• All patients with cirrhosis should be screened with EGD
• Primary prophylaxis– Large varices / decompensated patients : usually
nonselective B blocker– Banding and “sicker” patients
• Variceal bleed: abx, octreotide, Hgb 8,scope with banding– Blakemore/TIPS when in trouble
• Secondary prophylaxis– Combination B blocker / banding to eradication
![Page 30: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/30.jpg)
Ascites
![Page 31: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/31.jpg)
ASCITES
![Page 32: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/32.jpg)
Definition
• Fluid within the peritoneal cavity
• Occurs in 50-60% of patients with cirrhosis over 10-15 years
• Mixture of liver and intestinal lymph
![Page 33: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/33.jpg)
Cirrhosis Heart failure
Peritoneal tuberculosis
Cirrhosis is the Most Common Cause of Ascites
Others•Pancreatic •Budd-Chiari syndrome•Nephrogenic ascites
Peritoneal malignancy
CIRRHOSIS IS THE MOST COMMON CAUSE OF ASCITES
85%
33
![Page 34: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/34.jpg)
Ultrasound
![Page 35: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/35.jpg)
Pathophysiology
Elevated Hydrostatic Pressure
•Cirrhosis•Congestive heart failure•Constrictive pericarditis•Hepatic outflow block
Decreased Oncotic Pressure
•Nephrotic syndrome•Protein-losing enteropathy•Malnutrition•Cirrhosis
Peritoneal Fluid Production > Resorption
•Infections (bacterial, tuberculosis, fungal)•Neoplasms
![Page 36: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/36.jpg)
Hepatic Sinusoid• Unlike other capillaries, normal hepatic sinusoids
lack a basement membrane. • The sinusoidal endothelial cells themselves
contain large fenestrae (200-400 nm in diameter)
• These two features make the normal hepatic sinusoid very permeable with movement of fluid depending mostly on hydrostatic pressure
• Normal portal sinusoid pressure is 3-4 mmHg
36
![Page 37: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/37.jpg)
THE PERMEABILITY OF THE HEPATIC SINUSOID VARIES IN HEALTH AND DISEASE
In cirrhosis, the hepatic sinusoid is LESS leaky
The Permeability of the Hepatic Sinusoid Varies in Health and Disease
Hepatocytes
The normal sinusoid is “leaky”
Sinusoid
Sinusoid
fibrous tissue deposition “capillarization” of
sinusoid
no basement membrane
37
![Page 38: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/38.jpg)
Clinical Presentation
• Abdominal distention
• Bulging flanks
• Shifting dullness
• Fluid wave
• Fluid detected on US or CT scan
![Page 39: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/39.jpg)
Total Protein
(SAAG = serum albumin - ascitic albumin)
≥1.1 <1.1
<2.5 -Cirrhosis-Acute Liver Failure-Alcoholic Hepatitis-Massive Hepatic Mets
-Nephrotic syndrome-Myxedema
≥2.5 -CHF-Constrictive Pericarditis-Budd-Chiari-Venoocclusive Disease
-Peritoneal Carcinomatosis-TB Peritonitis-Pancreatic Ascites-Chylous Ascites-Serositis 39
Serum-Ascites Albumin Gradient
![Page 40: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/40.jpg)
Treatment of Ascites
• Usually responds to Na restriction and diuretics– When SAAG >1.1
• Dual diuretics:– Furosemide AND Spirololactone
• Single daily dosing (40/ 100)
• Na restriction– <2000mg/day
• Fluid restriction is usually NOT necessary
![Page 41: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/41.jpg)
Patients with Refractory Ascites Have Worse Survival than Patients with Diuretic-Responsive Ascites
Survival probability
1.0
.8
.6
.4
.2
0120 24 4836 60 8472
Refractory ascites
Non refractory ascites
p<0.001
Months
Salerno et al., Am J Gastroenterol 1993; 88:514
![Page 42: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/42.jpg)
In refractory ascites…
• AVOID– ACE inhibitors / angiotensin receptor blockers
• Blood pressure / adverse renal effects
– Propranolol• Blood pressure / circulatory dysfunction during
LVP• Renal function
– Consider risks benefits
– NSAIDS
![Page 43: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/43.jpg)
With Large / Tense ascites
• Therapeutic paracentesis followed by diuretics / Na restriction
• 6-8 g/of albumin per liter of ascites removed
• Midodrine may be helpful– Shown to increase BP, survival benefit
• Consideration of liver transplantation referral
![Page 44: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/44.jpg)
Complications of Ascites
• Hepatorenal syndrome– “The HRS Cocktail”
• Albumin + Octreotide + Midodrine
– In ICU: • Albumin + Norepineprhine
• Hepatic Hydrothorax– NO CHEST TUBE!!– Same as acsites (Na restrict / diuretics)
![Page 45: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/45.jpg)
Spontaneous Bacterial Peritonitis (SBP)
Infectious complications of cirrhosis1. Spontaneous bacterial peritonitis (SBP)2. Urinary tract infection3. Pneumonia4. Bacteremia
SBP 7-25% of hospitalized cirrhotics– In-hospital mortality 20-50%
Recurrence of SBP 30-70%
Borzio M Dig Liver Dis 2001;33(1):41-8Runyon Hepatology 2004
![Page 46: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/46.jpg)
Infecting Agents
Eschericia coli 43%
Klebsiella pneumoniae 8%
Streptococcus pneumoniae 8%
Alpha-hemolytic streptococcus 5%
Group D stretocococcus 8%
Miscellaneous Enterobacteriaceae 3%
Miscellaneous 20%
ASCITES
![Page 47: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/47.jpg)
Spontaneous Bacterial Peritonitis (SBP)
• Tap all patients admitted to hospital or for any reason rub you the wrong way…
• Diagnosis:– Culture NOT needed (but send it anyways)– PMN >250cells/mm3
• Treatment:– 3rd gen cephalpsporin ie cefotaxime 2g q8– Albumin 1.5g/kg day 1 and 1.0 g/kg day 3
• Cr >1, BUN >30, or bili >4
![Page 48: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/48.jpg)
SBP : prevention
• GI bleed and cirrhosis– Ceftriaxone or norflox x 7 days
• If prior episode of SBP, long term prophylaxis– Daily norfloxacin or bactrim
![Page 49: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/49.jpg)
Hepatic Encephalopathy
![Page 50: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/50.jpg)
Definition
• Reversible alteration in the neuropsychiatric function
• Due to shunting of neurotoxic nitrogenous products
• Lack of hepatic detoxification
![Page 51: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/51.jpg)
Hepatic Encephalopathy Pathogenesis
Bacterial actionProtein load
Failure to metabolize
NH3
NH3 Shunting
GABA-BD receptors
Toxins
![Page 52: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/52.jpg)
1 2 3 4
Coma
Somnolence
Confusion
Drowsiness
????
? ?
StagesHE
Adapted from AGA Teaching Slides.
![Page 53: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/53.jpg)
Hepatic Encephalopathy (HE)
• 10-50% of cirrhotics
• 40% survival 1 year after 1st episode
• 15% survival 3 years after 1st episode
• Disturbance in diurnal sleep pattern precedes neurologic signs
![Page 54: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/54.jpg)
Minimal Encephalopathy
• 15-30% have abnormal NCT or abnormal EEG without overt encephalopathy
• Significance unclear– impaired health-related quality of life
(HRQOL) compared to patients with cirrhosis without minimal HE
– impairs driving capacity and poor insight into their driving skills
• Not replicated in real life conditionsMetab Brain Dis 1998 Jun;13(2):159-72
Hepatology 1998 Jul;28(1):45-9
Metab Brain Dis 1995 Sep;10(3):239-48
![Page 55: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/55.jpg)
Kappus et al Clinical Gastroenterology and Hepatology, Volume 10, Issue 11, 2012, 1208 - 1219
Classification of Hepatic Encephalopathy
![Page 56: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/56.jpg)
Management of HE
• Identify / treat precipitating factors
• Empiric treatment – Rifaximin – Lactulose
![Page 57: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/57.jpg)
GI bleedingExcess protein
Sedatives / hypnotics
TIPSDiuretics
Serum K+
Plasma volume
Azotemia
Temp
Infections
Precipitating Factors of HE
![Page 58: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/58.jpg)
Ammonia Levels in HE
• May be correlation of ammonia levels and severity of HE
• Diagnosis and treatment is clinical– Should not change management– No utility in following levels
![Page 59: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/59.jpg)
Treatment of HE
• Lactulose– First line– 2-3 soft BM/ day
• Rifaximin– 550 BID– Reduced ammonia
producing bacteria
![Page 60: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/60.jpg)
Long Term Management of HE
• After initial HE event– Usually on therapy indefinitely or until liver
transplant
– Long term use of lactulose and or rifaximin
• High protein diet is OK (and preferred in cirrhosis)
• Patients with HE should NOT undergo TIPS if possible
![Page 61: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/61.jpg)
Hepatorenal Syndrome
![Page 62: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/62.jpg)
Pathophysiology
• Occurs in setting of cirrhosis and ascites
• Severe renal arterial vasoconstriction
• Compromised glomerular filtration rate
• Normal kidney structure
![Page 63: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/63.jpg)
1.0
0.8
0.6
0.4
0.2
0.0
Su
rviv
al
Type 1 hepatorenal syndrome
Months
Gines et al. NEJM 2004;350:1646-1654.
P<0.001
Creatinine <1.2 mg/dL
Creatinine 1.2-1.5mg/dL
Creatinine >1.5mg/dL
1.0
0.8
0.4
0.2
0.0
1 2 3 4 5
Years
Su
rviv
al
Refractory ascites
Survival in Cirrhosis Based on Level
of Renal Dysfunction
Survival Among Patients With Cirrhosis and HRS
1 2 3 4 500 6
0.6
00
Survival is Decreased with Renal Dysfunction
![Page 64: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/64.jpg)
Setting
•Advanced liver disease: cirrhosis, alcoholic hepatitits, fulminant hepatitis
•Sometimes precipitated by overdiuresis, GI bleed, use of nephrotoxic agents
Clinical Features•Ascites • Oliguria•Hypotension • Jaundice
Course•Typically death within weeks
Hepatorenal Syndrome
![Page 65: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/65.jpg)
Splanchnic/systemic vasodilatation
Intrahepatic resistance
Portal (sinusoidal) hypertension
Activation of neurohumoral systems
Cirrhosis
Effective arterial blood volume
Renal vasoconstriction
HEPATORENAL SYNDROME
![Page 66: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/66.jpg)
Type 1 and Type 2 HRS
• HRS Type 1– Rapidly progressive– Precipitating event frequent, esp SBP– Very short survival
• HRS Type 2– Slow onset of moderate renal insufficiency– Poor response to diuretics (refractory ascites)– Longer survival
![Page 67: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/67.jpg)
0 2 4 6 8 1210
Months
1
0.2
0.4
0.6
0.8
Survival probability
0
Type 2
p = 0.001
Gines et al., Lancet 2003; 362:1819
Type 1
Prognosis in Type 1 and 2 HRS
![Page 68: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/68.jpg)
Precipitants of Type 1 HRS
• Infection– Spontaneous bacterial peritonitis (SBP)– Urinary tract infection– Cellulitis
• Gastrointestinal hemorrhage• NSAID use• Large volume paracentesis without albumin• Adrenal insufficiency
![Page 69: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/69.jpg)
Salerno et al. Gut 2007
HRS Diagnostic Criteria
1. Cirrhosis with ascites
2. Serum CR >1.5 mg/dL
3. No improvement in serum CR after at least 2 days of diuretic withdrawal & volume expansion with albumin (max 100g/day)
4. Absence of shock
5. No current or recent nephrotoxic drugs
6. Absence of parenchymal kidney disease
![Page 70: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/70.jpg)
Clinical Characteristics of HRSAscites
Advanced liver disease
Low mean arterial pressure (median 74 mmHg)
Low serum Na (median 127 mEq/L)
Low urinary output
Do not rely on urine Na or urine sediment to differentiate HRS from ATN
Garcia-Tsao et al. Hepatology 2008
![Page 71: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/71.jpg)
Prevention of AKI in cirrhotics Careful use of diuretics & lactulose Albumin after large volume paracentesis Avoid NSAIDs & aminoglycosides Albumin & antibiotics for treatment of SBP Primary prophylaxis of SBP with
antibiotics Antibiotics for 5-7 days at time of GI bleed
![Page 72: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/72.jpg)
Precipitants
• Treatment principles• Treat the underlying precipitant promptly
• More quickly addressed the more likely to have improvement in HRS
• Have a high suspicion for an occult precipitating event in any liver patient who has ARF
• Even with removal of the precipitant, HRS may be irreversible
72
![Page 73: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/73.jpg)
Treatments
• Precipitating events
• Renal vasodilators
• Systemic vasoconstrictors
• TIPS
• Dialysis
• Transplantation
73
![Page 74: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/74.jpg)
Hepatocellular Carcinoma
![Page 75: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/75.jpg)
Hepatocellular Carcinoma
• Seen in cirrhosis– Exception: HBV (can be noncirrhotic)
• Diagnosis by US, CT scan, MRI– Histology is not essential
• Alpha-fetal protein level may be elevated
![Page 76: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/76.jpg)
Hepatocellular Carcinoma (HCC)
• Surveillance– Screen all patients with cirrhosis for HCC
• Up to 8% risk of HCC/year
– Also male HBV carriers >40 and female HBV >50 (even if they don’t have cirrhosis)
• Up to 0.6% risk of HCC/year
• For boards…screen with ultrasound q 6 months– No benefit to shorten interval– No benefit to screen with AFP– In practice many still use cross sectional imaging and
AFP to screen as well
![Page 77: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/77.jpg)
Diagnosis of HCC
• Usually with imaging, histology used less often
• If lesion seen on u/s> 1cm then follow up with CT or MR– If hypervascular lesion that washes out on
portal venous phase then dx with HCC– No bx needed
![Page 78: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/78.jpg)
CT appearance of HCC
Arterial Phase
Arterial Phase Washout
![Page 79: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/79.jpg)
Treatment of HCC
• Resection
• Local-Regional therapy– TACE– RFA– Ethanol ablation
• Liver transpantation
• Systemic– Sorafenib
![Page 80: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/80.jpg)
Treatment of HCC
• Resection– Less commonly used– Noncirrhotic or very well compensated
• Well preserved synthetic function (INR near normal)
• Normal bili• Low portal pressure
– Possibly for noncirrhotic HBV patient..– No role for adjuvant chemotherapy
![Page 81: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/81.jpg)
Treatment of HCC
• Local ablation– Alcohol injection
• Only in smaller tumors
• Not used very often
– Radiofrequency ablation• Better for larger tumors
– May use as a bridge to liver transplantation
![Page 82: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/82.jpg)
Treatment of HCC
• Transarterial Chemoebolization (TACE)– Non curative– Nonsurgical patients
– Large multifocal HCC– No vascular invasion– No extrahepatic spread
![Page 83: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/83.jpg)
Treatment of HCC
• Liver transplantation– Curative approach– Milan Criteria
• 1 tumor <5cm• Up to 3 tumors <3cm• No vascular / extrahepatic spread
– Tumor exception points• MELD=22
![Page 84: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/84.jpg)
Treatment of HCC
• Sorafenib– Last resort– Cannot benefit from resection, transplantation,
ablation or TACE– Multifocal disease with well preserved hepatic
function– SHARP trial median survival 10.7 months vs
7.9 months average survival
![Page 85: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/85.jpg)
Take Home: HCC
• Screen patients with u/s q6 months if they have cirrhosis / older patients with HBV
• Usually radiographic diagnosis– Biopsy rarely needed– Cross sectional imaging look for “arterial
enhancement” and “washout”
• Treatment:– Possibly “curative”: ablation, resection,
transplant– Palliative: TACE, sorafenib
![Page 86: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/86.jpg)
Prognostic Tools
![Page 87: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/87.jpg)
Prognostic Models
• Tools for predicting disease severity and death– Child-Turcotte-Pugh (CTP) score– Model or End-Stage Liver Disease (MELD)
![Page 88: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/88.jpg)
Child-Pugh-Turcotte Classification
1 2 3
Albumin (g/dl) >3.5 2.8-3.5 <2.8
Total bilirubin (mg/dl) <2 2-3 >3
Prothrombin time (INR) <1.7 1.7-2.3 >2.3
Ascites None Medically Uncontrolled
controlled
Encephalopathy (grade) 0 I-II III-IV
Class: A = 5-6 points, B = 7-9 points, C = 10-15 points
![Page 89: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/89.jpg)
MELD Score
• Model for Endstage Liver Disease
• MELD = INR, Creatinine, Bilirubin
• Higher scores (6 to 40) indicate worse prognosis
• MELD >15 would benefit from liver transplant
![Page 90: Complications of cirrhosis review](https://reader034.vdocuments.net/reader034/viewer/2022051016/55a720b21a28ab504a8b48ae/html5/thumbnails/90.jpg)
Conclusions
• The transition from compensated cirrhosis to decompensated cirrhosis carries a significant change in mortality
• Clinical diagnosis is important
• Simultaneous compications may (and usually arise)